Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2025

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Year Ended December 31,
	2025		2024		2023
	(in thousands)
Insurance carriers	$	2,171,186	$	1,571,817	$	954,155
Laboratory partners		103,112		97,210		98,891
Patients		31,815		27,884		29,525
Total revenues	$	2,306,113	$	1,696,911	$	1,082,571

Schedule of total revenue by geographic area

	Year ended December 31,
	2025		2024		2023
	(in thousands)
United States	$	2,264,265	$	1,657,745	$	1,047,636
Americas, excluding U.S.		9,354		6,620		4,908
Europe, Middle East, India, Africa		24,480		23,884		22,811
Asia Pacific and Other		8,014		8,662		7,216
Total	$	2,306,113	$	1,696,911	$	1,082,571

Schedule of changes in the balance of deferred revenues

	Balance at		Balance at
	December 31,		December 31,
	2025		2024
	(in thousands)
Beginning balance	$	36,592	$	35,740
Increase in deferred revenues(1)		50,455		35,440
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(19,200)		(13,693)
Revenue recognized from performance obligations satisfied within the same period		(25,878)		(20,895)
Ending balance	$	41,969	$	36,592